Consumer Defensive [ 11/13 ] | Education & Training Services [ 103/163 ]
NASDAQ | Common Stock
Afya Limited operates as a medical education group in Brazil.
The company operates through three segments: Undergrad, Continuing Education, and Digital Services.
It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others.
It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy.
In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services.
Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients.
The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 9, 24 | 0.42 Decreased by -76.54% | 0.46 Decreased by -8.22% |
| Mar 14, 24 | 1.79 Increased by +29.71% | 1.55 Increased by +15.48% |
| Nov 13, 23 | 1.38 Increased by +7.81% | 1.36 Increased by +1.47% |
| Aug 28, 23 | 1.42 Increased by +26.79% | 1.41 Increased by +0.71% |
| May 24, 23 | 1.80 Decreased by -1.64% | 2.03 Decreased by -11.33% |
| Mar 22, 23 | 1.38 Increased by +31.43% | 1.37 Increased by +0.73% |
| Nov 21, 22 | 1.28 Increased by +7.56% | 1.38 Decreased by -7.25% |
| Aug 22, 22 | 1.12 Increased by +75.00% | 0.98 Increased by +14.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 804.24 M Increased by +13.28% | 203.39 M Increased by +81.40% | Increased by +25.29% Increased by +60.14% |
| Dec 31, 23 | 729.87 M Increased by +24.98% | 98.06 M Increased by +47.03% | Increased by +13.44% Increased by +17.65% |
| Sep 30, 23 | 723.48 M Increased by +24.61% | 93.35 M Increased by +23.21% | Increased by +12.90% Decreased by -1.12% |
| Jun 30, 23 | 712.61 M Increased by +19.13% | 82.79 M Decreased by -18.44% | Increased by +11.62% Decreased by -31.54% |
| Mar 31, 23 | 709.96 M Increased by +42.49% | 112.12 M Increased by +149.34% | Increased by +15.79% Increased by +74.99% |
| Dec 31, 22 | 584.00 M Increased by +17.21% | 66.69 M Increased by +48.31% | Increased by +11.42% Increased by +26.54% |
| Sep 30, 22 | 580.58 M Increased by +27.77% | 75.76 M Increased by +42.86% | Increased by +13.05% Increased by +11.81% |
| Jun 30, 22 | 598.16 M Increased by +60.63% | 101.50 M Increased by +488.88% | Increased by +16.97% Increased by +266.60% |